Pharmaceutical Medicine is a leading journal published by SPRINGER INT PUBL AG, dedicated to the field of pharmacology and pharmaceutical sciences. With ISSN 1178-2595 and E-ISSN 1179-1993, this journal serves as an essential platform for researchers and professionals to share groundbreaking findings and advancements in medication efficacy, safety, and innovative therapeutic strategies. Recognized for its contribution to the field, Pharmaceutical Medicine holds an impressive Q2 ranking in both Pharmacology and Medical Pharmacology categories, further underscored by its competitive Scopus rankings—positioned at 100/272 (63rd percentile) in Medical Pharmacology and 156/313 (50th percentile) in Pharmacology, Toxicology, and Pharmaceutics. Although it primarily operates on a traditional subscription basis, its robust academic reputation continues to attract a diverse readership worldwide. Addressed in the United Kingdom with facilities in Switzerland, the journal publishes authoritative articles from its inception in 2000 through to 2024, making it a pivotal resource for those seeking to enhance their understanding and application of pharmacological principles in clinical practice and research.

Pediatric Quality & Safety is an esteemed Open Access journal aimed at enhancing the well-being and care of pediatric patients through rigorous research and innovative practices. Published by Lippincott Williams & Wilkins since 2016, this journal provides a platform for the dissemination of critical findings in the fields of pediatrics, perinatology, and child health, boasting a respectable impact factor that places it in the Q2 category for 2023, ranking #173 out of 330 in its field. With a commitment to improving healthcare outcomes, Pediatric Quality & Safety not only offers comprehensive coverage of current research trends but also promotes best practices among healthcare professionals. It welcomes contributions from researchers, clinicians, and students alike, making it an invaluable resource for anyone dedicated to advancing pediatric care. The journal is accessible for readers worldwide, reflecting a growing emphasis on open-access knowledge and collaboration.

Expert Opinion on Drug Safety is a prestigious academic journal dedicated to advancing knowledge in the fields of drug safety and pharmacology. Published by Taylor & Francis Ltd, this journal serves as an essential resource for researchers and professionals seeking to explore the complexities of drug interactions, adverse effects, and risk management. With an impressive impact factor and recognized as a Q1 journal in both the Medicine (Miscellaneous) and Pharmacology (Medical) categories, it ranks favorably at #78 out of 272 in Scopus, placing it in the 71st percentile among its peers. Operating under a rigorous peer-review process, the journal publishes original research, expert reviews, and opinion pieces that contribute to a deeper understanding of drug safety practices. While not an open access journal, it remains a vital platform for disseminating pivotal findings and fostering scholarly dialogue, ensuring that critical insights reach a global audience. With continuous publication from 2002 to 2024, Expert Opinion on Drug Safety is a key reference for anyone involved in pharmaceutical research, healthcare practice, or drug regulation.

The Journal of Health and Safety at Work, published by the Iranian Occupational Health Association, is a vital resource for researchers, professionals, and students engaged in the fields of occupational health, safety, and environmental management. With an ISSN of 2251-807X and E-ISSN 2383-2088, this Open Access journal has been dedicated to disseminating knowledge since 2012, ensuring that critical research is accessible to a global audience. The journal’s scope encompasses a diverse range of topics including human factors and ergonomics, safety research, and public health, with a focus on enhancing workplace safety and environmental standards. Although currently positioned in the Q4 category across various disciplines within safety and health research, the journal offers a unique platform for emerging studies and innovative practices, making it a significant contributor to the discourse in these fields. The journal's commitment to open access aligns with the growing trend of transparent scholarship, thus facilitating the sharing of vital insights to improve workplace health and safety outcomes. Researchers aiming to publish groundbreaking studies in this pivotal area will find the Journal of Health and Safety at Work an indispensable avenue for advancing knowledge and fostering professional collaboration.

American Journal of Medical Quality is a pivotal publication in the field of healthcare quality and medical policy, published by Lippincott Williams & Wilkins. Since its inception in 1992, the journal has become a critical resource for researchers, practitioners, and students dedicated to improving patient care and health systems through evidence-based practices. With a current impact factor that reflects its significance in the arena of medicine and health policy, the journal falls within the Q3 category in both Health Policy and Medicine (Miscellaneous) as of 2023, ranking 253rd out of 636 in general medicine according to Scopus metrics. This underscores its relevance and prominence among peers. The journal's scope encompasses a diverse range of topics related to quality improvement initiatives, healthcare delivery systems, and policy analysis, making it an essential read for anyone invested in advancing medical quality standards and practices. While it is not an open-access journal, the content is meticulously curated to enrich the academic discourse and inform best practices in medical quality. With an ongoing commitment to addressing contemporary challenges in healthcare, American Journal of Medical Quality serves as an influential platform for advancing the knowledge and implementation of quality initiatives in medical settings.

BRITISH JOURNAL OF HOSPITAL MEDICINE is a distinguished publication in the field of medicine, focusing primarily on the latest research, clinical practices, and advancements in hospital medicine. Published by MA HEALTHCARE LTD in the United Kingdom, this journal serves as a critical resource for healthcare professionals, researchers, and students alike, featuring insightful articles that bridge the gap between theory and practice. Holding a Q3 ranking in the miscellaneous medicine category and positioned within the top half of Scopus rankings, the journal underscores its commitment to high-quality, peer-reviewed content. With its inception dating back to 1996, the BRITISH JOURNAL OF HOSPITAL MEDICINE has evolved to include a broad spectrum of topics relevant to contemporary hospital settings, ensuring its readers are well-equipped with the knowledge necessary for improving patient care. Access options are tailored to modern readership, enhancing the visibility and dissemination of vital medical research.

SAFETY SCIENCE, published by Elsevier in the Netherlands, is a premier international journal dedicated to advancing the fields of safety research, public health, environmental and occupational health, and risk management. With an impressive impact factor and recognized as a Q1 journal in multiple categories for 2023, its rigorous peer-reviewed articles are essential for researchers, professionals, and students alike. The journal covers a wide range of topics designed to influence safety practices and policies globally. Although Open Access options are not available, the substantial insights provided in each issue underscore the journal's critical role in enhancing the understanding of safety and risk dynamics in a constantly evolving world. With a convergence of knowledge from the years 1991 to 2025, SAFETY SCIENCE remains at the forefront of evidence-based research, stimulating essential dialogues and innovations that shape our approach to safety in various domains.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, an esteemed publication in the field of pharmacology, is published by Wiley-Hindawi and has been at the forefront of clinical research since its inception in 1976. Operating primarily from the United Kingdom, this journal features a diverse array of articles that encompass both fundamental and practical aspects of clinical pharmacy, thereby supporting the advancement of therapeutic practices. With an ISSN of 0269-4727 and an E-ISSN of 1365-2710, it is indexed in key databases and holds respectable ranks within its categories; achieving Q3 in Pharmacology and Q2 in Medical Pharmacology in the latest quartile rankings. Its Scopus ranking reflects both its quality and relevance, being positioned in the 55th percentile for medical pharmacology and the 45th for pharmacology, toxicology, and pharmaceutics. Although it does not currently operate under an Open Access model, the journal's extensive readership and rigorous peer-review process ensure that the latest research reaches practitioners and academics alike. With a commitment to bridging the gap between pharmacological science and clinical practice, the JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS remains a critical resource for professionals striving to enhance patient outcomes through informed medication management.

The Journal of Patient Safety, published by Lippincott Williams & Wilkins, is a premier scholarly journal dedicated to advancing the field of patient safety through empirical research, innovative practices, and critical insights. Established in 2006, this journal has rapidly gained recognition, currently holding a prestigious Q1 ranking in Leadership and Management and a Q2 ranking in Public Health, Environmental and Occupational Health for 2023, reflecting its significant impact within these disciplines. With an impressive rank of #7 in Nursing Leadership and Management and #211 in Medicine Public Health as recorded in Scopus, this journal serves as an essential resource for researchers, healthcare professionals, and students committed to improving patient safety and outcomes. The journal does not operate as an open access publication; however, its comprehensive scope and high-quality articles underscore its dedication to disseminating crucial knowledge in a field that is ever-evolving. Joining the readership of the Journal of Patient Safety means becoming part of a vital conversation aimed at redefining standards of care and enhancing safety protocols across various healthcare settings.

Therapeutics and Clinical Risk Management is a pioneering journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the fields of medication safety, pharmacology, and clinical risk management through rigorous research and comprehensive reviews. With an impact factor that demonstrates its significance within various disciplines, this Open Access journal has been instrumental since its inception in 2006, promoting the dissemination of knowledge to a global audience without barriers. With its reach spanning categories such as Pharmacology, Medicine, and Chemical Health and Safety, it champions innovative practices and risk assessment methodologies. The journal is recognized in the Q2 quartile for multiple related categories and excels in rank within its field, highlighting its influential contributions to safety and therapeutic practices. By prioritizing the sharing of impactful research, Therapeutics and Clinical Risk Management serves as an indispensable resource for researchers, professionals, and students aiming to enhance clinical outcomes and mitigate risks in therapeutic paradigms.